China SXT Pharmaceuticals Inc
NASDAQ:SXTC
Cash Flow Statement
Cash Flow Statement
China SXT Pharmaceuticals Inc
| Mar-2018 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||
| Net Income |
1
|
(2)
|
(10)
|
(7)
|
(3)
|
(7)
|
(6)
|
(4)
|
(6)
|
(14)
|
(3)
|
6
|
(3)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Deffered Taxes |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
1
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
2
|
9
|
8
|
3
|
2
|
3
|
4
|
4
|
12
|
1
|
(7)
|
2
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
1
|
(1)
|
2
|
1
|
(2)
|
4
|
2
|
(0)
|
1
|
1
|
(0)
|
(1)
|
(1)
|
|
| Cash from Operating Activities |
2
N/A
|
(2)
N/A
|
1
N/A
|
3
+182%
|
(1)
N/A
|
(1)
+2%
|
0
N/A
|
0
-89%
|
(0)
N/A
|
(0)
-38%
|
(2)
-1 653%
|
(3)
-40%
|
(2)
+13%
|
|
| Investing Cash Flow | ||||||||||||||
| Capital Expenditures |
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
|
| Other Items |
(0)
|
(5)
|
(5)
|
3
|
(6)
|
(18)
|
0
|
9
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(5)
-382%
|
(6)
0%
|
3
N/A
|
(6)
N/A
|
(18)
-207%
|
(0)
+100%
|
9
N/A
|
(0)
N/A
|
(0)
-200%
|
0
N/A
|
0
+78%
|
0
+35%
|
|
| Financing Cash Flow | ||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
2
|
0
|
0
|
0
|
3
|
|
| Net Issuance of Debt |
(0)
|
9
|
7
|
(2)
|
(0)
|
(0)
|
2
|
2
|
4
|
4
|
(1)
|
0
|
(0)
|
|
| Other |
0
|
(2)
|
(4)
|
(1)
|
13
|
8
|
(4)
|
(11)
|
(3)
|
3
|
(2)
|
9
|
6
|
|
| Cash from Financing Activities |
(0)
N/A
|
7
N/A
|
3
-56%
|
(4)
N/A
|
12
N/A
|
8
-34%
|
2
-81%
|
(6)
N/A
|
3
N/A
|
10
+225%
|
(3)
N/A
|
9
N/A
|
8
-7%
|
|
| Change in Cash | ||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
(0)
|
(0)
|
0
|
1
|
1
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
1
|
(0)
|
|
| Net Change in Cash |
1
N/A
|
(1)
N/A
|
(2)
-108%
|
2
N/A
|
6
+200%
|
(10)
N/A
|
2
N/A
|
3
+33%
|
2
-39%
|
8
+372%
|
(5)
N/A
|
7
N/A
|
6
-14%
|
|
| Free Cash Flow | ||||||||||||||
| Free Cash Flow |
1
N/A
|
(2)
N/A
|
1
N/A
|
2
+373%
|
(1)
N/A
|
(1)
+9%
|
0
N/A
|
(0)
N/A
|
(0)
-400%
|
(0)
-7%
|
(2)
-1 110%
|
(3)
-40%
|
(2)
+13%
|
|